Literature DB >> 2023448

Surgical management of lung metastases. Usefulness of resection with the neodymium:yttrium-aluminum-garnet laser with median sternotomy.

K Kodama1, O Doi, M Higashiyama, M Tatsuta, T Iwanaga.   

Abstract

Between May 1969 and September 1989, 677 metastatic lesions were resected during 107 operations in 100 patients with pulmonary metastases from various primary sites at the Center for Adult Diseases, Osaka, Japan. Of those patients, 65 underwent conventional lateral thoracotomy, and 35 patients had median sternotomy. No significant difference existed in actuarial survival after the first operation to remove the metastases between the two patients groups. Furthermore, local excision of 418 lesions was performed in 25 patients with the neodymium:yttrium-aluminum-garnet (Nd:YAG) laser. Of those, 18 patients had undergone a one-stage operation for bilateral lesions through a median sternotomy approach. Although our study was not randomized, survival of the 25 patients treated with the Nd:YAG laser tends to be longer than survival of the 75 patients for whom the Nd:YAG laser was not used. We concluded that aggressive excision and evaporation of multiple lung metastases with the Nd:YAG laser under median sternotomy is a safe and promising variation in technique and that this approach will expand the scope of surgical indications for metastatic lung tumors. For a clearer demonstration of the influence of differences in surgical techniques on long-term survival it is necessary to conduct randomized prospective studies of the surgical techniques.

Entities:  

Mesh:

Year:  1991        PMID: 2023448

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  9 in total

Review 1.  Pulmonary metastasectomy: outcomes and issues according to the type of surgical resection.

Authors:  Masahiko Higashiyama; Toshiteru Tokunaga; Tomoyuki Nakagiri; Daisuke Ishida; Hidenori Kuno; Jiro Okami
Journal:  Gen Thorac Cardiovasc Surg       Date:  2015-04-03

2.  Transmediastinal approach to exploring the lung contralateral to the thoracotomy site.

Authors:  K Kodama; M Higashiyama; H Yokouchi; K Takami; Y Doki; T Kabuto
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-05

3.  Surgery for multiple lung metastases from alveolar soft-part sarcoma.

Authors:  K Kodama; O Doi; M Higashiyama; H Yokouchi; K Kuriyama; T Ueda; H Yoshikawa
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

4.  Surgical treatment for metastatic lung tumors with incidentally coexisting lung cancer.

Authors:  M Higashiyama; K Kodama; H Yokouchi; K Takami; M Kameyama; K Kuriyama
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1999-04

Review 5.  Pulmonary metastasectomy in colorectal cancer: a systematic review and quantitative synthesis.

Authors:  Francesca Fiorentino; Ian Hunt; Kristine Teoh; Tom Treasure; Martin Utley
Journal:  J R Soc Med       Date:  2010-02       Impact factor: 5.344

6.  A new approach for performing a one-stage operation through the mediastinum to resect bilateral lung metastases: report of a case.

Authors:  K Kodama; O Doi; M Higashiyama; H Yokouchi; T Aihara; T Ueda
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

7.  Synchronous pulmonary atypical adenomatous hyperplasia and metastatic osteosarcoma in a young female.

Authors:  Ken Kodama; Masahiko Higashiyama; Koji Takami; Naozumi Higaki; Kazuyuki Oda; Nobuhito Araki
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2004-07

8.  Surgery for pulmonary metastases from colorectal cancer: the importance of prethoracotomy serum carcinoembryonic antigen as an indicator of prognosis.

Authors:  Masahiko Higashiyama; Ken Kodama; Naozumi Higaki; Koji Takami; Kohei Murata; Masao Kameyama; Hideoki Yokouchi
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-07

Review 9.  Lung Metastases: Current Surgical Indications and New Perspectives.

Authors:  Giuseppe Mangiameli; Ugo Cioffi; Marco Alloisio; Alberto Testori
Journal:  Front Surg       Date:  2022-04-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.